三個皮匠報告
政策庫
new
付費
搜索

圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力-行業數據

圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力
變患者效果較弱，需要 5 倍劑量給藥治療，并且對很多突變不敏感。奧雷巴替尼對大部分 TKI 不敏感的激酶區突變和復合突變激酶均有較強抑制性。
行業數據 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?51KB 圖片尺寸：1730*785
同報告圖片
 / 30
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第1頁
fCBNdXRhdGVkIHJlZ2lvbiB8IEltYXRpbmliICAgICAgIHwgTmlsb3RpbmliICAgICAgfCBEYXNhdGluaWIgICAgIHwgQXNjaW1pbmliICAgICB8IFBvbmF0aW5pYiAgICB8IE92b3JhYmF0aW5pYiB8CnwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfAp8IFdpbGQtdHlwZSAgICAgIHwgLSAgICAgICAgICAgICAgfCA1NjUgwrEgNjU2ICAgICAgfCAzMSDCsSA0ICAgICAgICB8IDEwIMKxIDMgICAgICAgIHwgMTEgICAgICAgICAgIHwgNiDCsSAzICAgICAgICB8CnwgU0gyLWNvbnRyYWN0IHJlZ2lvbiB8IE0zNTFUICAgICAgICAgIHwgMTI5OCDCsSA1NDIgICAgIHwgMzcgwrEgNCAgICAgICAgfCA4IMKxIDQgICAgICAgICB8IDQ3IMKxIDM0ICAgICAgfCAxMyDCsSAxICAgICAgIHwKfCBTdWJzdHJhdGUtYmluZGluZyByZWdpb24gfCBGMzU5ViAgICAgICAgICB8ID4xMDAwMCAgICAgICAgIHwgMTcxMCDCsSA2MzUgICAgfCA1OTggwrEgNjI0ICAgICB8IDYwNjYgwrEgMzU1ICAgfCA1MCDCsSAxNiAgICAgIHwKfCAgICAgICAgICAgICAgICAgIHwgRTI1NUsgICAgICAgICAgfCA4MjIyIMKxIDQ4NCAgICAgfCA2NDggwrEgMzk1ICAgICB8IDE0IMKxIDEgICAgICAgIHwgMTAgICAgICAgICAgIHwgNDkgwrEgNCAgICAgICB8CnwgUC1sb29wICAgICAgICAgIHwgWTI1M0ggICAgICAgICAgfCA4OTM2IMKxIDE3NzQgICAgfCA0OTcgwrEgMTIyICAgICB8IDExIMKxIDIgICAgICAgIHwgMjggwrEgMTMgICAgICB8IDM3IMKxIDQgICAgICAgfAp8ICAgICAgICAgICAgICAgICAgfCBFMjU1ViAgICAgICAgICB8IDc1NjUgwrEgMzI2MyAgICB8IDU4NyDCsSAxNTEgICAgIHwgMjkgwrEgMTUgICAgICAgfCAyNCDCsSA0ICAgICAgIHwgNTYgwrEgMSAgICAgICB8CnwgR2F0ZSBrZWVwZXIgICAgIHwgTTI0NFYgICAgICAgICAgfCAyOTYzIMKxIDgzICAgICAgfCAyMzYgwrEgMTUyICAgICB8IDQwIMKxIDEgICAgICAgIHwgNTIyMyDCsSA0ODk5ICB8IDQxIMKxIDggICAgICAgfAp8ICAgICAgICAgICAgICAgICAgfCBUMzE1SSAgICAgICAgICB8ID4xMDAwMCAgICAgICAgIHwgMzQyNSDCsSA2NTAgICAgfCAyNTI1IMKxIDMyMiAgICB8IDE0OCDCsSAxNCAgICAgfCAzMyDCsSAxMSAgICAgIHwKfCBIaW5nZSByZWdpb24gICAgfCBGMzE3TCAgICAgICAgICB8IDUyNiDCsSA2NiAgICAgICB8IDg5IMKxIDggICAgICAgIHwgMTEgwrEgMSAgICAgICAgfCA2IMKxIDMgICAgICAgIHwgNyDCsSAxICAgICAgICB8CnwgICAgICAgICAgICAgICAgICB8IEYzMTFMICAgICAgICAgIHwgMzU0NyDCsSAyMjMgICAgIHwgMjI2IMKxIDEyMiAgICAgfCAxMyDCsSAwICAgICAgICB8IDEwNyDCsSAxICAgICAgfCAzMCDCsSA4ICAgICAgIHwKfCBTSDMtY29udGFjdCByZWdpb24gfCBWMjk5TCAgICAgICAgICB8IDE5ODcgwrEgMTIzNyAgICB8IDEwMyDCsSA2ICAgICAgIHwgMTE4IMKxIDIgICAgICAgfCA1NjIgwrEgNTUyICAgIHwgMTAgwrEgNCAgICAgICB8CnwgICAgICAgICAgICAgICAgICB8IFQzMTVJL0UyNTVWICAgIHwgPjEwMDAwICAgICAgICAgfCA2NDY3IMKxIDQ0MzEgICB8IDM1NzEgwrEgMTM4NSAgIHwgOTMgwrEgODYgICAgICB8IDI0NCDCsSAxMjUgICAgfAp8ICAgICAgICAgICAgICAgICAgfCBUMzE1SS9GMzU5ViAgICB8ID4xMDAwMCAgICAgICAgIHwgNDU4NiDCsSAxMzk3ICAgfCAzMzkyIMKxIDIxMSAgICB8IDY2MzEgwrEgMTIwMSAgfCAxMDEgwrEgMjIgICAgIHwKfCAgICAgICAgICAgICAgICAgIHwgVDMxNUkvRzI1MEUgICAgfCA+MTAwMDAgICAgICAgICB8IDg1MTEgwrEgNTU5OSAgIHwgNTAwMSDCsSAyOTM5ICAgfCA3NDUxIMKxIDMwNTcgIHwgMTMwIMKxIDE2ICAgICB8CnwgICAgICAgICAgICAgICAgICB8IFQzMTVJL0UyNTVLICAgIHwgPjEwMDAwICAgICAgICAgfCA+MTAwMDAgICAgICAgIHwgNDcwNiDCsSA4MDMgICAgfCA4OTQ0IMKxIDc0OCAgIHwgMzM5IMKxIDEyICAgICB8CnwgICAgICAgICAgICAgICAgICB8IFQzMTVJL0U0NTNLICAgIHwgODQ2OCDCsSAxNjI4ICAgIHwgPjEwMDAwICAgICAgICB8IDQ3MjQgwrEgMTU1ICAgIHwgMjkzMSDCsSA3NCAgICB8IDEzMCDCsSA1ICAgICAgfAp8IFQzMTVJICsgT3RoZXIgQ29tcG91bmQgTXV0YXRpb24gfCBUMzE1TS9UMzE1SSAgICB8IDc2MDMgwrEgMTQ5OCAgICB8ID4xMDAwMCAgICAgICAgfCA3NjgzIMKxIDM2NDUgIHwgPjEwMDAwICAgICAgIHwgMTI3IMKxIDUgICAgICB8CnwgICAgICAgICAgICAgICAgICB8IFQzMTVJL00zNTFUICAgIHwgNzE0NCDCsSAyNDU5ICAgIHwgPjEwMDAwICAgICAgICB8IDQ3ODkgwrEgMTczOSAgIHwgNzA2MSDCsSAxNDIzICB8IDQzOCDCsSA4OCAgICAgfAp8ICAgICAgICAgICAgICAgICAgfCBUMzE1SS9IMzk2UiAgICB8IDg5NTMgwrEgNTMxNCAgICB8ID4xMDAwMCAgICAgICAgfCA5MjY2IMKxIDMzOTYgICB8ID4xMDAwMCAgICAgICB8IDIxMSDCsSAxMzQgICAgfAp8ICAgICAgICAgICAgICAgICAgfCBUMzE1SS9ZMjUzSCAgICB8ID4xMDAwMCAgICAgICAgIHwgPg==
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第2頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第3頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第4頁
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
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第5頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第6頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第7頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第8頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第9頁
fCDmsrvnlpfml7bpl7QgfCBOPTI1IHwg5rK755aX5pe26Ze077yI5pyI77yJIHwgTj03IHwg5rK755aX5pe26Ze077yI5pyI77yJIHwKfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfAp8IFBSIHwgNCAoMTYlKSB8IDExLjcgfCAtIHwgLSB8CnwgU0QgfCAyMCAoODAlKSB8IDguMSB8IDYuMCB8IDUuMSB8CnwgUEQgfCAxICg0JSkgfCAtIHwgMS4wIHwgLSB8CgoqKui1hOaWmeadpea6kCoqOiBOQ0NO5oyH5Y2XLCBDU0NP5oyH5Y2XLCBIVEk=
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第10頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第11頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第12頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第13頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第14頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第15頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第16頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第17頁
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
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第18頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第19頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第20頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第21頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第22頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第23頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第24頁
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
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第25頁
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
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第26頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第27頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第28頁
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
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第29頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第30頁
圖8不同BCR-ABL抑制劑對野生型BCR-ABL及其突變型的抑制能力_第31頁
所屬報告： 亞盛醫藥-港股公司首次覆蓋報告：厚積薄發逐步邁向全球化Biopharma-241010（37頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站